Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-08IONS3Director Peter N. Reikes Reports No Securities Ownership in Ionis Pharmaceuticals
This Form 3 filing reports that Peter N. Reikes, a director of Ionis Pharmaceuticals Inc., has no securities ownership in the company as of June 4, 2026. The filing was submitted on June 5, 2026, and signed by attorney-in-fact Patrick R. O'Neil on behalf of Mr. Reikes. The document indicates that Mr. Reikes serves as a...
Large CapBiotechnology